24 maj: Neonet Securities ændrer CD-ident for afvikling af handler
24 maj: Dagens ändringar 2012-05-24
24-05-2012 17:05:00

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associate

Relateret indhold
18 dec - 
Torsdagens aktier: I topform med Vestas og Mærsk i spid..
18 dec - 
Aktier/middag: Mærsk og Vestas trækker stærk kursoffens..
18 dec - 
Aktier/åbning: Mærsk og Vestas øverst i kraftigt stigen..
Relateret debat
19 dec - 
Efter de seneste udmeldinger, tror jeg at Lundbeck nuvæ..
19 dec - 
Hvad mener I der skal ske med Lundbeck? De annoncerede ..
13 dec - 
Er de ikke fortsat presset af patentudløb? Da kursen va..

H. Lundbeck A/S hereby reports transactions made by executives and persons and

legal entities closely associated to them with shares in H. Lundbeck A/S and

linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the company's

executives today or yesterday.

Name: Anders Gersel Pedersen

Job position of the Executive Vice President &

executive: Head of Research & Development

ID code (ISIN code): DK 0010287234

Description of the Share

security:

Nature of the transaction: Transferred as part of Lundbeck’s Long Term

Incentive Program for Executive Management

Date of trading: 23 May 2012

Market on which the Nasdaq OMX Copenhagen

trading was effected:

Number of traded 33,583 shares

securities:

Persons or entities under an obligation to report are defined as members of the

Executive Management and the Supervisory Board of H. Lundbeck A/S and

persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

-- spouse or cohabitant

-- children below the age of 18

-- legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group’s

financial expectations for 2012.

Lundbeck contacts

Investors: Media:

Palle Holm Olesen Mads Kronborg

Chief Specialist, Head of Investor Relations Media Relations Manager

palo@lundbeck.com mavk@lundbeck.com

+45 36 43 24 26 +45 36 43 28 51

Magnus Thorstholm Jensen Simon Mehl Augustesen

Investor Relations Officer International Media Specialist

matj@lundbeck.com smeh@lundbeck.com

+45 36 43 38 16 +45 36 43 49 80

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is an international pharmaceutical

company highly committed to improving the quality of life for people suffering

from brain disorders. For this purpose, Lundbeck is engaged in the research,

development, production, marketing and sale of pharmaceuticals across the

world. The company’s products are targeted at disorders such as depression and

anxiety, psychotic disorders, epilepsy and Huntington’s, Alzheimer’s and

Parkinson’s diseases.

Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today

Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the

world’s leading pharmaceutical companies working with brain disorders. In 2011,

the company's revenue was DKK 16.0 billion (approximately EUR 2.1 billion or

USD 3.0 billion). For more information, please visit www.lundbeck.com.

Vedhæftet fil: Release no 471_1.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Vestas vinder ordre på 34 MW i Tyrkiet - NY

19-12-2014 16:36:45
Vestas har fredag vundet en tyrkisk ordre på levering af 17 vindmøller med en samlet kapacitet på 34 megawatt.Det fremgår af en pressemeddelelse fra den danske ..

Novo Nordisk: Tresiba får positiv anbefaling om brug til børn

19-12-2014 13:26:58
En lægemiddelkomité under de europæiske sundhedsmyndigheder, EMA, anbefaler en udvidet indikation af diabetesmidlet Tresiba.Lægemiddelkomitéen, CHMP, anbefaler,..

Aktier/middag:Carlsberg presset i positivt C20

19-12-2014 11:42:20
Noget tyder på, at julestemningen har smittet af på investorerne på det danske aktiemarked. I hvert fald gør købelysten på det danske C20 Cap-indeks sig gældend..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Nye stigninger på vej
2
Novo Nordisk: Tresiba får positiv anbefaling om brug til børn
3
Nordjyske-formand: Vi er helt oppe på tåspidserne
4
Aktier/åbning: Vestas igen forrest for pæn stigning
5
Tidligere OW Bunker-chef er fængslet for bedrageri - NY

Relaterede aktiekurser

H Lundbeck A/S 121,80 -0,7% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.

Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
20. december 2014 06:51:29
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141211.1 - EUROWEB6 - 2014-12-20 06:51:29 - 2014-12-20 06:51:29 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x